How Economic Analysis Increases the Awareness of Clinical Services: A Case of Diabetes Mellitus at a Teaching Hospital in Myanmar
Issued Date
2022-05-01
Resource Type
File Type
video/youtube
ISSN
22121099
eISSN
22121102
Scopus ID
2-s2.0-85119265768
Pubmed ID
34800825
Journal Title
Value in Health Regional Issues
Volume
29
Start Page
21
End Page
27
Rights Holder(s)
SCOPUS
Bibliographic Citation
Value in Health Regional Issues Vol.29 (2022) , 21-27
Suggested Citation
Khaing Oo W.W., Riewpaiboon A., Youngkong S., Ko K. How Economic Analysis Increases the Awareness of Clinical Services: A Case of Diabetes Mellitus at a Teaching Hospital in Myanmar. Value in Health Regional Issues Vol.29 (2022) , 21-27. 27. doi:10.1016/j.vhri.2021.09.001 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/84529
Title
How Economic Analysis Increases the Awareness of Clinical Services: A Case of Diabetes Mellitus at a Teaching Hospital in Myanmar
Author(s)
Author's Affiliation
Other Contributor(s)
Abstract
Objectives: Myanmar faces a growing epidemic of type 2 diabetes mellitus, which has significant impact on the individual health and health service system; nevertheless, reliable cost estimate for treating diabetes is still unknown. Therefore, this study aimed to explore the treatment cost of hospitalization by type 2 diabetes mellitus and the association of complications and comorbidities with the treatment cost. Methods: The retrospective incidence-based cost of illness analysis was performed at the diabetes ward of 800-bed teaching hospital in Yangon, Myanmar. The data were retrieved from hospital financial reports and patient's medical records for the fiscal year 2017 to 2018. Data was analyzed by using descriptive statistics and multivariate statistics. One-way sensitivity analysis was used to assess the uncertainty of input parameters. Results: This study involved 87 inpatients with type 2 diabetes mellitus with an average length of stay of 16.1 ± 12.6 days. Of the study sample, 67% had complications whereas 74% had comorbidities. The average treatment cost per admission was $718.7 (equal to 58% of gross domestic product - GDP per capita) at 2018 prices. Based on the multiple regression analysis, cost savings per admission were $276.5, $307.3, and $319.5 from preventing foot ulcer, nephropathy, and retinopathy, respectively. Conclusions: This study found that the treatment of diabetes is costly because of its preventable health consequences. Better disease management to prevent complications results in considerable cost savings. This quantitative evidence would increase awareness in health service system.